560 However, these biomarker changes are not exclusive to mitochondrial diseases and can also be observed in other conditions, 554,561 necessitating further research into their sensitivity and specificity
148 These drugs act by simultaneously targeting three different agonists GLP-1R, the GIPR, and the GCGR
In addition, if you're one of the millions of Americans taking proton pump inhibitors (PPIs) that suppress stomach acid for conditions like acid reflux, you're going to be prone to vitamin B12 deficiency
A first-in-human Phase I clinical trial at UC San Diego (NCT05040217) is testing AAV2-BDNF gene therapy in 12 patients with early Alzheimers disease and MCI
The GLP-1 Dosing Optimizer calculates the per-injection dose, peak-trough profile, and plasma curve for any frequency
Buonocore D, Grosini M, Giardina S, et al